^
    3years
    Assessment of Safety and Preliminary Clinical Efficacy With BAT6005 in Advanced Malignant Solid Tumors (clinicaltrials.gov)
    P1, N=36, Not yet recruiting, Bio-Thera Solutions
    Clinical • New P1 trial
    |
    TIGIT (T Cell Immunoreceptor With Ig And ITIM Domains 2)
    |
    BAT6005